Publication details

p53 Binds Preferentially to Non-B DNA Structures Formed by the Pyrimidine-Rich Strands of GAA center dot TTC Trinucleotide Repeats Associated with Friedreich's Ataxia

Investor logo
Authors

HELMA R. BAZANTOVA P. PETR M. ADAMIK M. RENCIUK D. TICHY V. PASTUCHOVA A. SOLDANOVA Z. PECINKA P. BOWATER R.P. FOJTA Miroslav BRAZDOVA M.

Year of publication 2019
Type Article in Periodical
Magazine / Source Molecules
MU Faculty or unit

Central European Institute of Technology

Citation
Web https://www.mdpi.com/1420-3049/24/11/2078
Doi http://dx.doi.org/10.3390/molecules24112078
Keywords trinucleotide repeat; p53; non-B DNA; DNA hairpin; DNA-protein; frataxin
Description Expansions of trinucleotide repeats (TNRs) are associated with genetic disorders such as Friedreich's ataxia. The tumor suppressor p53 is a central regulator of cell fate in response to different types of insults. Sequence and structure-selective modes of DNA recognition are among the main attributes of p53 protein. The focus of this work was analysis of the p53 structure-selective recognition of TNRs associated with human neurodegenerative diseases. Here, we studied binding of full length p53 and several deletion variants to TNRs folded into DNA hairpins or loops. We demonstrate that p53 binds to all studied non-B DNA structures, with a preference for non-B DNA structures formed by pyrimidine (Py) rich strands. Using deletion mutants, we determined the C-terminal DNA binding domain of p53 to be crucial for recognition of such non-B DNA structures. We also observed that p53 in vitro prefers binding to the Py-rich strand over the purine (Pu) rich strand in non-B DNA substrates formed by sequence derived from the first intron of the frataxin gene. The binding of p53 to this region was confirmed using chromatin immunoprecipitation in human Friedreich's ataxia fibroblast and adenocarcinoma cells. Altogether these observations provide further evidence that p53 binds to TNRs' non-B DNA structures.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info